Skip to main content

Table 2 Significantly mutated genes in tumor samples of 510 patients with LUAD. The genes were classified as oncogene (OG) and tumor suppressor gene (TSG) based on their scores and the cancer gene census information by SomInaClust R package

From: Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma

Gene

# Mutations

qDG

OG Score

TSG Score

Classification

CGCa

KRAS

143

1.97e-250

97.8

0

OG

Dom

TP53

253

2.52e-135

79.7

38

TSG

Rec

EGFR

73

8.97e-84

73.8

10

OG

Dom

STK11

83

4.6e-61

27.8

72

TSG

Rec

BRAF

44

8.07e-51

67.5

7.4

OG

Dom

RBM10

39

9.06e-31

0

78.9

TSG

NA

NF1

63

5.37e-25

0

54.2

TSG

Rec

MGA

52

6.46e-23

0

58.3

TSG

NA

SETD2

44

1.34e-20

16.7

58.1

TSG

Rec

RB1

32

4.99e-20

0

68.8

TSG

Rec

PIK3CA

27

1.36e-19

61.5

0

OG

Dom

ATM

48

5.18e-18

25

45.7

TSG

Rec

CTNNB1

21

3.32e-15

61.1

12.5

OG

Dom

ARID1A

30

1.76e-14

12.5

60

TSG

Rec

ARID2

29

2.83e-12

0

57.1

TSG

Rec

SMARCA4

48

2.23e-11

16.7

42.9

TSG

Rec

CSMD3

324

6.25e-10

0

17.5

NA

NA

ATF7IP

17

1.84e-08

0

71.4

TSG

NA

KEAP1

90

1.91e-08

9.8

24.1

TSG

NA

NFE2L2

14

2.83e-07

58.3

0

OG

Dom

KDM5C

16

1.76e-06

0

60

TSG

Rec

ERBB2

13

6.94e-06

55.6

14.3

OG

Dom

LRP1B

267

6.04e-05

0

15.6

NA

Rec

HMCN1

97

8.93e-05

0

24.1

TSG

NA

MAP2K1

9

0.000263

66.7

0

OG

Dom

APC

24

0.000272

0

37.5

TSG

Rec

PNISR

6

0.000626

0

83.3

TSG

NA

RPL5

7

0.000626

0

83.3

TSG

Dom

GNAS

19

0.000962

28.6

0

OG

Dom

COL11A1

129

0.00139

0

18.1

NA

NA

EPHA5

66

0.00221

0

23.4

TSG

NA

TTK

18

0.00221

0

41.2

TSG

NA

FBXW7

12

0.0028

40

50

TSG

Rec

DMD

99

0.00349

0

18.8

NA

NA

SMAD4

20

0.00379

30

35

TSG

Rec

FER

16

0.0043

0

46.2

TSG

NA

MARK1

21

0.0043

0

46.2

TSG

NA

TEP1

29

0.0043

0

46.2

TSG

NA

ATRX

35

0.00463

0

26.5

TSG

Rec

CDKN2A

21

0.00585

37.5

35

TSG

Rec

MYO9A

19

0.00615

0

42.9

TSG

NA

ZNF800

17

0.00615

0

42.9

TSG

NA

CMTR2

26

0.00674

0

55.6

TSG

NA

RASA1

9

0.00674

0

55.6

TSG

NA

CDKN1B

5

0.00674

0

80

TSG

Rec

DHX15

7

0.00674

0

80

TSG

NA

IQGAP2

28

0.00816

0

40

TSG

NA

LTN1

19

0.00816

0

40

TSG

NA

SMARCA1

19

0.00816

0

40

TSG

NA

SPTA1

164

0.00971

0

17.6

NA

NA

FHOD3

31

0.0122

0

30.4

TSG

NA

CPVL

8

0.0161

0

66.7

TSG

NA

MAP3K12

8

0.0161

0

66.7

TSG

NA

TOP2B

9

0.0161

0

66.7

TSG

NA

ROCK1

21

0.0163

0

35.3

TSG

NA

PBRM1

12

0.0172

0

45.5

TSG

Rec

AKAP6

40

0.0195

0

28

TSG

NA

SENP1

3

0.0241

0

100

TSG

NA

SP1

4

0.0241

0

100

TSG

NA

WISP3

4

0.0241

0

100

TSG

NA

RAD50

13

0.0243

20

41.7

TSG

NA

COL28A1

19

0.0243

0

41.7

TSG

NA

SCAF8

18

0.0243

0

41.7

TSG

NA

STK31

19

0.0243

0

41.7

TSG

NA

IDH1

6

0.0248

40

25

TSG

Dom

USH2A

240

0.0263

0

13.2

NA

NA

YLPM1

23

0.0269

0

31.6

TSG

NA

IQUB

12

0.0272

0

57.1

TSG

NA

MARK2

10

0.0272

0

57.1

TSG

NA

NAA15

8

0.0272

0

57.1

TSG

NA

CDH10

99

0.028

0

16.4

NA

NA

AKT1

3

0.0296

66.7

0

OG

Dom

RAF1

7

0.031

66.7

0

OG

Dom

VPS13C

39

0.0332

0

25

TSG

NA

ZBBX

28

0.0333

0

30

TSG

NA

DST

67

0.0333

0

19.1

NA

NA

KMT2C

52

0.0388

0

18.8

NA

Rec

DGKB

38

0.0431

0

28.6

TSG

NA

MAP2K4

8

0.045

33.3

50

TSG

Rec

FBN2

93

0.045

0

20.5

TSG

NA

B2M

8

0.045

0

50

TSG

Rec

BAP1

8

0.045

0

50

TSG

Rec

  1. aCancer gene census (Dom Dominant, Rec Recessive)